» Articles » PMID: 19151778

A New Molecular Network Comprising PU.1, Interferon Regulatory Factor Proteins and MiR-342 Stimulates ATRA-mediated Granulocytic Differentiation of Acute Promyelocytic Leukemia Cells

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2009 Jan 20
PMID 19151778
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

In the acute promyelocytic leukemia (APL) bearing the t(15;17), all-trans-retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. We identified miR-342 as one of the microRNAs (miRNAs) upregulated by ATRA during APL differentiation. This miRNA emerged as a direct transcriptional target of the critical hematopoietic transcription factors PU.1 and interferon regulatory factor (IRF)-1 and IRF-9. IRF-1 maintains miR-342 at low levels, whereas the binding of PU.1 and IRF-9 in the promoter region following retinoic ATRA-mediated differentiation, upregulates miR-342 expression. Moreover, we showed that enforced expression of miR-342 in APL cells stimulated ATRA-induced differentiation. These data identified miR-342 as a new player in the granulocytic differentiation program activated by ATRA in APL.

Citing Articles

Crosstalk of Transcriptional Regulators of Adaptive Immune System and microRNAs: An Insight into Differentiation and Development.

Boshtam M, Rahimmanesh I, Shariati L, Najaflu M, Khanahmad H, Mirian M Cells. 2023; 12(4).

PMID: 36831302 PMC: 9953855. DOI: 10.3390/cells12040635.


Benzene Exposure and MicroRNAs Expression: In Vitro, In Vivo and Human Findings.

Mozzoni P, Poli D, Pinelli S, Tagliaferri S, Corradi M, Cavallo D Int J Environ Res Public Health. 2023; 20(3).

PMID: 36767288 PMC: 9914606. DOI: 10.3390/ijerph20031920.


Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Sabo A, Dudau M, Constantin G, Pop T, Geilfus C, Naccarati A Front Pharmacol. 2021; 12:652074.

PMID: 34295245 PMC: 8290364. DOI: 10.3389/fphar.2021.652074.


The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision.

Herbst F, Lang T, Eckert E, Wunsche P, Wurm A, Kindinger T Leukemia. 2021; 35(10):2948-2963.

PMID: 34021250 PMC: 8478659. DOI: 10.1038/s41375-021-01267-5.


Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements Multiple Signaling Pathways.

Qu M, Duan Y, Zhao M, Wang Z, Zhao M, Zhao Y Front Oncol. 2021; 11:659720.

PMID: 33842376 PMC: 8033199. DOI: 10.3389/fonc.2021.659720.